349 related articles for article (PubMed ID: 11923701)
1. Complete freedom from rejection after intestinal transplantation using a new tolerogenic protocol combined with low immunosuppression.
Pirenne J; Koshiba T; Geboes K; Emonds MP; Ferdinande P; Hiele M; Nevens F; Waer M
Transplantation; 2002 Mar; 73(6):966-8. PubMed ID: 11923701
[TBL] [Abstract][Full Text] [Related]
2. Intestinal graft versus native liver cytokine expression in a rat model of intestinal transplantation with and without donor-specific cell augmentation.
Levay-Young B; Gruessner SE; Shearer JD; Cheol Kim S; Nahkleh RE; Gruessner RW
J Surg Res; 2003 Sep; 114(1):78-89. PubMed ID: 13678702
[TBL] [Abstract][Full Text] [Related]
3. Tolerogenic protocols for intestinal transplantation.
Pirenne J; Kawai M
Transpl Immunol; 2004; 13(2):131-7. PubMed ID: 15380543
[TBL] [Abstract][Full Text] [Related]
4. Evolutionary experience with immunosuppression in pediatric intestinal transplantation.
Bond GJ; Mazariegos GV; Sindhi R; Abu-Elmagd KM; Reyes J
J Pediatr Surg; 2005 Jan; 40(1):274-9; discussion 279-80. PubMed ID: 15868597
[TBL] [Abstract][Full Text] [Related]
5. Intestinal transplantation: evolution in immunosuppression protocols.
Pirenne J; Kawai M
Curr Opin Organ Transplant; 2009 Jun; 14(3):250-5. PubMed ID: 19373085
[TBL] [Abstract][Full Text] [Related]
6. Tolerogenic protocol for intestinal transplantation.
Pirenne J; Kawai M
Transplant Proc; 2006; 38(6):1664-7. PubMed ID: 16908241
[TBL] [Abstract][Full Text] [Related]
7. The Leuven Immunomodulatory Protocol Promotes T-Regulatory Cells and Substantially Prolongs Survival After First Intestinal Transplantation.
Ceulemans LJ; Braza F; Monbaliu D; Jochmans I; De Hertogh G; Du Plessis J; Emonds MP; Kitade H; Kawai M; Li Y; Zhao X; Koshiba T; Sprangers B; Brouard S; Waer M; Pirenne J
Am J Transplant; 2016 Oct; 16(10):2973-2985. PubMed ID: 27037650
[TBL] [Abstract][Full Text] [Related]
8. Intestinal graft versus native liver cytokine expression in a rat model of intestinal transplantation: effect of donor-specific cell augmentation.
Levay-Young B; Shearer JD; Gruessner AC; Kim SC; Nahkleh RE; Gruessner RW
Transplant Proc; 2004 Mar; 36(2):399-400. PubMed ID: 15050172
[TBL] [Abstract][Full Text] [Related]
9. [Clinical results of intestinal and multivisceral transplantation at the Charité, Berlin. A case series].
Pascher A; Klupp J; Schulz RJ; Kohler S; Junge G; Sauer IM; Veltzke-Schlieker W; Adler A; Guckelberger O; Nüssler NC; Dignass A; Langrehr JM; Neuhaus P
Dtsch Med Wochenschr; 2005 Feb; 130(8):387-92. PubMed ID: 15717248
[TBL] [Abstract][Full Text] [Related]
10. Portal donor-specific blood transfusion and mycophenolate mofetil allow steroid avoidance and tacrolimus dose reduction with sustained levels of chimerism in a pig model of intestinal transplantation.
Gruessner RW; Levay-Young BK; Nakhleh RE; Shearer JD; Dunning M; Nelson CM; Gruessner AC
Transplantation; 2004 May; 77(10):1500-6. PubMed ID: 15239611
[TBL] [Abstract][Full Text] [Related]
11. [Intestinal transplantation from the laboratory to the clinic].
Pirenne J
Verh K Acad Geneeskd Belg; 2004; 66(3):197-211; discussion 211-3. PubMed ID: 15315120
[TBL] [Abstract][Full Text] [Related]
12. Donor-specific portal blood transfusion in intestinal transplantation: a prospective, preclinical large animal study.
Gruessner RW; Nakhleh RE; Harmon JV; Dunning M; Gruessner AC
Transplantation; 1998 Jul; 66(2):164-9. PubMed ID: 9701258
[TBL] [Abstract][Full Text] [Related]
13. Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning.
Shapiro R; Jordan ML; Basu A; Scantlebury V; Potdar S; Tan HP; Gray EA; Randhawa PS; Murase N; Zeevi A; Demetris AJ; Woodward J; Marcos A; Fung JJ; Starzl TE
Ann Surg; 2003 Oct; 238(4):520-5; discussion 525-7. PubMed ID: 14530723
[TBL] [Abstract][Full Text] [Related]
14. Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft.
Donckier V; Troisi R; Toungouz M; Colle I; Van Vlierberghe H; Jacquy C; Martiat P; Stordeur P; Zhou L; Boon N; Lambermont M; Schandené L; Van Laethem JL; Noens L; Gelin M; de Hemptinne B; Goldman M
Transpl Immunol; 2004; 13(2):139-46. PubMed ID: 15380544
[TBL] [Abstract][Full Text] [Related]
15. Contribution of large animal models to the development of clinical intestinal transplantation.
Pirenne J
Acta Gastroenterol Belg; 1999; 62(2):221-5. PubMed ID: 10427786
[TBL] [Abstract][Full Text] [Related]
16. Steroid-free immunosuppression during and after liver transplantation--a 3-yr follow-up report.
Pirenne J; Aerts R; Koshiba T; Van Gelder F; Roskams T; Schetz M; Verhaegen M; Lauwers P; Fevery J; Nevens F
Clin Transplant; 2003 Jun; 17(3):177-82. PubMed ID: 12780665
[TBL] [Abstract][Full Text] [Related]
17. Repeating intraportal donor-specific transfusion may induce tolerance following adult living-related donor liver transplantation.
Sato Y; Ichida T; Watanabe H; Yamamoto S; Oya H; Nakatsuka H; Kobayashi T; Watanabe T; Kameyama H; Hatakeyama K
Hepatogastroenterology; 2003; 50(51):601-6. PubMed ID: 12828042
[TBL] [Abstract][Full Text] [Related]
18. Up-to-date evolution of small bowel transplantation in children with intestinal failure.
Jan D; Michel JL; Goulet O; Sarnacki S; Lacaille F; Damotte D; Cezard JP; Aigrain Y; Brousse N; Peuchmaur M; Rengeval A; Colomb V; Jouvet P; Ricour C; Révillon Y
J Pediatr Surg; 1999 May; 34(5):841-3; discussion 843-4. PubMed ID: 10359192
[TBL] [Abstract][Full Text] [Related]
19. Exfoliative rejection after intestinal transplantation in children.
Ishii T; Mazariegos GV; Bueno J; Ohwada S; Reyes J
Pediatr Transplant; 2003 Jun; 7(3):185-91. PubMed ID: 12756042
[TBL] [Abstract][Full Text] [Related]
20. Current status of intestinal transplantation in children.
Reyes J; Bueno J; Kocoshis S; Green M; Abu-Elmagd K; Furukawa H; Barksdale EM; Strom S; Fung JJ; Todo S; Irish W; Starzl TE
J Pediatr Surg; 1998 Feb; 33(2):243-54. PubMed ID: 9498395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
